Approximately 6.8 million people die annually because of problems related to the central
nervous system (CNS), and out of them, approximately 1 million people are affected by …

Schizophrenia (SZ) is a devastating neurodevelopmental disease with an accelerated
ageing feature. The criteria of metabolic disease firmly fit with those of schizophrenia …

Depression is one of the most common mental illnesses, affecting almost 300 million people.
According to the WHO, depression is one of the world's leading causes of disability and …

Аннотация Шизофрения характеризуется нейрохимическими, морфологическими,
биоэлектрическими и поведенческими изменениями в организме, системная …

Synaptic plasticity is an important basis of learning and memory and participates in brain
network remodelling after different types of brain injury (such as that caused by …

Study aimed to design and development of a supramolecular formulation of sulpiride (SUL)
to enhance its solubility, dissolution and permeability by targeting a novel GlyT1 inhibition …

This study explores a comparative analysis of PLGA nanoparticles and liposomes as
potential carriers for brain cancer drug delivery, with a special focus on how material …

Prescribing rate of antipsychotics in elderly patients with psychiatric illnesses has been
increasing all over the world. However, there is a lack of research examining the use of …

Background: Silymarin is a flavonolignan extracted from Silybum marianum with various
therapeutic applications. Many studies have focused on improving the bioavailability of …

Disorders in the brain and peripheral nervous system cause neurodegenerative diseases.
Many of the drugs commonly used in the diagnosis and treatment of neurodegenerative …